Drug composition for treating cerebral infarction or/and coronary heart disease stenocardia and preparation method and application thereof

A technology for coronary heart disease angina pectoris and a composition is applied in the field of pharmaceutical compositions for the treatment of cerebral infarction or/and coronary heart disease angina pectoris, and can solve problems such as difficulty in obtaining curative effects and the like
CN104523734AActive Publication Date: 2015-04-22SICHUAN CHUANDA WEST CHINA PHARMA
2 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
SICHUAN CHUANDA WEST CHINA PHARMA
Publication Date
2015-04-22

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to a drug composition for treating cerebral infarction or / and coronary heart disease stenocardia. The drug composition is prepared from the following active ingredients of, by weight, 1-10 parts of paeoniflorin, 1-5 parts of hydroxyl safflower pigment A and 0.1-0.5 part of rutin. The invention further provides a preparation method and application of the drug composition. The problems that only one single drug is used, action targets are fewer, the drug achieves the treatment purpose through one target, and the consumed drug dosage is large are solved. Based on the principle of achieving the same goal by different ways, the three drugs acting on different mechanisms are combined, the drugs are synergistic and interact, the effect of the drugs is superior to the summing effect of the independent drug solid, and therefore the purpose of treating or preventing cardiovascular and cerebrovascular diseases is achieved. Paeoniflorin, hydroxyl safflower pigment A and rutin are different in action mechanisms in the aspect of treating the cardiovascular and cerebrovascular diseases and have the synergistic effect when matched in the application process, and the treatment effect is superior to that of single application only when the three drugs are combined together to be applied.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a pharmaceutical composition for treating cerebral infarction or / and coronary heart disease angina pectoris. Background technique

[0002] my country is a country with a high incidence of cerebrovascular diseases. With the continuous improvement of people's material living standards and the increase of the aging population, the incidence is rapidly increasing. Cerebral infarction, cerebral arteriosclerosis, coronary heart disease, angina pectoris and other cardiovascular and cerebrovascular diseases seriously threaten human life and health. According to epidemiological investigations, the incidence and death of cardiovascular and cerebrovascular diseases have The mortality rate of cardiovascular and cerebrovascular diseases in my country has jumped to the top of various diseases.

[0003] Cerebral infarction refers to multiple ischemic softening infarcts in the brain, also known as multiple encephalomalacia, accompanied by para...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More